IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 198 filers reported holding IMPAX LABORATORIES INC in Q4 2015. The put-call ratio across all filers is 0.81 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $861,000 | -33.3% | 44,265 | -42.9% | 0.03% | -25.0% |
| Q4 2017 | $1,291,000 | -26.4% | 77,531 | +89.1% | 0.04% | +48.1% |
| Q4 2015 | $1,753,000 | +21.4% | 41,000 | 0.0% | 0.03% | +8.0% |
| Q3 2015 | $1,444,000 | -23.3% | 41,000 | 0.0% | 0.02% | -7.4% |
| Q2 2015 | $1,883,000 | -14.5% | 41,000 | -12.8% | 0.03% | -18.2% |
| Q1 2015 | $2,203,000 | +59.9% | 47,000 | +8.0% | 0.03% | +57.1% |
| Q4 2014 | $1,378,000 | +39.8% | 43,500 | +4.6% | 0.02% | +50.0% |
| Q3 2014 | $986,000 | -21.0% | 41,600 | 0.0% | 0.01% | -26.3% |
| Q2 2014 | $1,248,000 | +13.6% | 41,600 | 0.0% | 0.02% | +5.6% |
| Q1 2014 | $1,099,000 | +28.8% | 41,600 | 0.0% | 0.02% | +12.5% |
| Q3 2013 | $853,000 | – | 41,600 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aravt Global | 3,071,878 | $131,354,000 | 13.28% |
| BANBURY PARTNERS LLC | 480,179 | $20,532,000 | 8.33% |
| Krensavage Asset Management, LLC | 585,170 | $25,022,000 | 7.98% |
| Hound Partners | 6,980,266 | $298,476,000 | 6.77% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 295,000 | $12,614,000 | 4.25% |
| GIOVINE CAPITAL GROUP LLC | 59,805 | $2,557,000 | 3.72% |
| ATERNALIS CAPITAL LLC | 130,000 | $5,559,000 | 3.65% |
| Asymmetry Capital Management, L.P. | 51,430 | $2,199,000 | 3.32% |
| Orbimed Advisors | 6,664,100 | $284,957,000 | 2.58% |
| Pennant Capital Management, LLC | 2,321,581 | $99,271,000 | 2.52% |